Remuneration of CEO/COO
Jackie Fairley joins Starpharma in 2005 as COO
4/7/5 - 30/6/6 Cash remuneration $322,270
Becomes CEO on 30/6/7
1/7/6 - 30/6/7 Cash remuneration $479,019
2008 - $526,880
2009 - $437,841
2010 - $1,653,921
2011 - $693,052
2012 - $695,210
2013 - $933,775
2014 - $1,303,543
2015 - $1,319,269
2016 - $1,287,151
2017 - $1,266,581
2018 - $1,692,817
Total $12,611,329
Total shares held in company as of 30/6/18
2,190,886 in her name
Total current value - $3,198,693.56
The number of ordinary shares in the company provided as remuneration during the financial year, including close family members and entities related to her
3,875,4340
The number of rights over ordinary shares in the company provided as remuneration during the financial year and the KMP , including their close family members and entities related to them
2,890,829
So you can see from the above Jackie Fairley is and has been well remunerated in her position of COO and CEO over the years
This does not include the shares she has sold in this period
Thoughts
Expand
